| HOME >> BIOLOGY >> TECHNOLOGY |
Jacob P. Lalezari, MD, is the Director of Quest Clinical Research and an Assistant Clinical Professor of Medicine at UCSF/Mount Zion Hospital. Previously, he served as co-director of the HIV Clinical Research Center at Mt. Zion Medical Center and also at the University of California in San Francisco. Since 1989, Dr. Lalezari has served as a Principal Investigator for Phase 1, 2, and 3 clinical studies of new therapies for viral diseases including HIV/AIDS, CMV, HPV, HSV, Hepatitis B & C, Influenza, and RSV.
Graeme Moyle, MBBS, MD, is the Director of HIV Research Strategy at the Chelsea and Westminster Hospital, London. After graduating from the University of Adelaide, Australia, he moved to the United Kingdom and began working in HIV and AIDS working mostly at the Chelsea and Westminster Hospital but also gaining experience in HIV drug development, clinical trial design and management from within the pharmaceutical industry. He is a regular presenter of original research at international conferences, is the author of around 130 peer-reviewed publications on HIV, and Editor of The Journal of Viral Entry.
M. Keith Rawlings, MD, is Medical Director for the AIDS Arms/ Peabody Health Center in Dallas, Texas. Dr. Rawlings is currently Chair, Internal Medicine Section of the National Medical Association (NMA), and since 1994 has served as Co-Chair of the Infectious Diseases/ HIV program. Dr. Rawlings has provided direct comprehensive medical care to underserved individuals living with HIV for over 20 years.
Michael Saag, MD, is the Director of the Center for AIDS Research and
the Division of Infectious Diseases and International Health in the
Department of Medicine at the
'/>"/>
| SOURCE Ardea Biosciences, Inc. Copyright©2008 PR Newswire. All rights reserved |